表紙
市場調査レポート

モバイルヘルスの世界市場 (機器、サービス、アプリケーション、ステークホルダー、地域別) - 産業分析、市場規模、シェア、動向、企業プロファイル、需要、考察、機会および予測:2014-2020年

Global mHealth Market (Devices, Services, Application, Stakeholders and Geography) - Industry Analysis, Market Size, Share, Growth, Company Profiles, Demand, Insights, Opportunities, Trends and Forecast, 2014 - 2020

発行 Allied Market Research 商品コード 332536
出版日 ページ情報 英文 165 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
モバイルヘルスの世界市場 (機器、サービス、アプリケーション、ステークホルダー、地域別) - 産業分析、市場規模、シェア、動向、企業プロファイル、需要、考察、機会および予測:2014-2020年 Global mHealth Market (Devices, Services, Application, Stakeholders and Geography) - Industry Analysis, Market Size, Share, Growth, Company Profiles, Demand, Insights, Opportunities, Trends and Forecast, 2014 - 2020
出版日: 2015年05月01日 ページ情報: 英文 165 Pages
概要

モバイルヘルス (mHealth) は、深刻な慢性疾患に悩む患者の遠隔モニタリングに通信機器を利用する革命的医療サービスを提供する電子ヘルス (eHealth) の一分野。モバイルヘルスは、複数の疾患に対するモニタリングおよび治療に向けて、主にモバイルおよびワイヤレス技術を利用します。糖尿病、肥満症、高血症、慢性閉塞性肺疾患 (COPD) 、閉塞性睡眠時無呼吸症 (OSA) ほかの生活習慣病の増加から、先進技術を駆使し、時間をかけない疾患予防・治療の差し迫ったニーズが生じました。世界保健機構 (WHO) によれば、2012年のCOPDによる死亡者数は推定310万人、世界死亡者総数のおよそ5.6%にのぼります。さらに、同年の脳卒中による死亡者数は約670万、全体の11.%に相当。心臓や呼吸、血糖値のモニタリングなど携帯電話利用の医療サービスの継続導入が疾患に対する定期検査・治療ニーズへの対策として機能してきました。モバイルヘルスの世界市場規模は2014年の時点で105億ドルに相当し、今後2020年まで33.5%の複合年間成長率で拡大する見込みです。

当レポートでは、モバイルヘルスの世界市場に注目し、2014-2020年の期間にわたる取引規模の推移を機器、サービス、アプリケーション、ステークホルダーおよび地域 (北米、欧州、アジア太平洋地域、中南米・中東・アフリカ) の別に分析・予測するほか、市場発展の推進・抑制要因、産業構造、競合環境、主要参入企業などについての最新情報を集めています。

第1章 イントロダクション

  • レポート内容
  • レポートの主要利点
  • 主要市場セグメント
  • 調査方法
    • 二次情報調査
    • 一次情報取材
    • 分析ツールおよびモデル

第2章 エグゼクティブサマリー

  • 経営首脳の視点
  • 今後2025年までの市場予測
    • 基本シナリオ
    • 急成長シナリオ
    • 危機的成長シナリオ

第3章 市場概要

  • 市場の定義と範囲
  • 重要所見
    • モバイルヘルスの世界市場に対する最有力影響ファクター
    • 最有力投資ポケット - モバイルヘルスの世界市場
    • 最有力成功戦略 - モバイルヘルスの世界市場
  • Porterのファイブフォース分析
  • バリューチェーン分析
    • 一次活動
    • 二次活動
  • 規制問題、法令、監督機関
    • 米国のモバイルヘルスに関する規制および指令
    • 欧州のモバイルヘルスに関する規制および指令
  • 保険・報酬シナリオ
  • 参入企業の位置関係:2014年
  • 治験:2011-2015年
  • 特許分析:2011-2015年
    • 米国特許分析
    • 欧州特許分析
    • 日本の特許分析
  • 市場動態
    • 推進要因
      • 携帯医療機器を伴うワイヤレス技術の一本化
      • 生活習慣病患者の増加
      • コストおよび利便性ファクター
      • 技術革新
      • 行政府優遇措置
      • スマートフォンの値ごろ感
    • 抑制要因
      • 開発途上・低開発地域における意識の欠如および技術の未熟による低導入率
      • 医療報酬制度の不備
      • 老齢人口の技術認識
      • 行政府規制の不透明性が成長の足枷に
    • 機会
      • 手付かずの開発途上国市場
      • バンドルサービス形式に浮上する商機

第4章 モバイルヘルスの世界市場 - 機器別:2014-2020年

  • 血糖値計
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
  • 血圧計
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
  • パルスオキシメトリー
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
  • 神経学的モニタリング
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
  • 心臓モニター
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
  • 無呼吸睡眠モニター
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
  • ウェアラブルセンサー機器および心拍計
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
  • その他
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測

第5章 モバイルヘルスの世界市場 - サービス別:2014-2020年

  • 予防
    • 市場規模および予測
  • 診断サービス
    • 市場規模および予測
  • モニタリングサービス
    • 市場規模および予測
  • 治療
    • 市場規模および予測
  • アプリケーション/コンテンツ供給企業
    • 市場規模および予測

第6章 モバイルヘルスの世界市場 - ステークホルダー別

  • モバイル通信事業者
    • 市場規模および予測
  • 機器供給企業
    • 市場規模および予測
  • 医療プロバイダー
    • 市場規模および予測
  • アプリケーション/コンテンツ供給企業
    • 市場規模および予測

第7章 モバイルヘルスの世界市場 - 用途別

  • 心血管科
    • 市場規模および予測
  • 糖尿病科
    • 市場規模および予測
  • 呼吸器下科
    • 市場規模および予測
  • 神経科
    • 市場規模および予測

第8章 モバイルヘルスの世界市場 - 地域別

  • 北米
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • ロシア
    • その他欧州諸国
  • アジア太平洋地域
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
    • オーストラリア
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域諸国
  • 中南米、中東・アフリカ
    • 重要市場動向
    • 重要成長ファクターおよび商機
    • 市場規模および予測
    • 中南米
    • 中東
    • アフリカ

第9章 企業プロファイル (企業概要、企業寸評、事業概要、業績、戦略的動き・展開、SWOT分析など)

  • LifeWatch AG
  • Masimo Corporation
  • オムロン ヘルスケア
  • Philips healthcare (a division of Royal Philips companyの一事業部門)
  • Bayer healthcare (Bayerの一事業部門)
  • Sanofi
  • Boston Scientific Corporation
  • AT&T Inc.
  • JOHNSON & JOHNSON
目次
Product Code: ME 15676

Mobile health (mHealth) is a branch of electronic health (eHealth) that delivers revolutionized healthcare service in which communication devices are used for the remote monitoring of patients suffering from acute and chronic diseases. mHealth majorly involves the use of mobile and wireless technologies, which are deployed in monitoring and treatment of several diseases. Rising prevalence of lifestyle diseases such as diabetes, obesity, hypertension, chronic obstructive pulmonary disease (COPD and obstructive sleep apnea (OSA) and other diseases has created an impending need of technologically advanced and less time consuming methods for prevention and treatment of these diseases. According to the World Health Organization (WHO), there were an estimated 3.1 million deaths due to COPD in 2012, which accounted for around 5.6% of all deaths worldwide. Further, nearly 6.7 million deaths occurred due to stroke in 2012, which represented around 11.9% of all deaths across the globe. The continued introduction of mobile phone based medical devices such as cardiac monitors, respiratory monitors and blood glucose monitors has addressed the need of regular monitoring and treatment of diseases in the market.

The global mHealth market was valued $10.5 billion in 2014 growing at a CAGR of 33.5% from 2015 to 2020, primarily driven by the increasing prevalence of lifestyle diseases, growing government initiatives and rising adoption of smart phones across the globe. Currently, the market is experiencing a resurgence due to the increased mobile penetration, which is more than 100% in developed markets and the similar trends in developing markets such as Asia-Pacific and Africa. Despite the mentioned benefits, low accuracy and technology infancy related to mHealth devices especially in developing and under-developed regions are the major factors limiting the growth of mHealth market.

The global mHealth market is segmented into devices, services, application, stakeholders and geography. Based on device type, the market is further segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring devices, apnea and sleep monitors, wearable fitness sensor device & heart rate meters and others. BP monitors hold the dominant share in device types segment, however, blood glucose meters is estimated to be the fastest growing segment in the global mHealth devices market. This is due to the factors such as incidences of hypertension, sedentary lifestyle, increasing cases of diabetes, etc. Based on services, the market is further segmented into diagnosis services, monitoring services, prevention, treatment and wellness & healthcare system strengthening solutions. Monitoring services occupy the dominant share in the mHealth services market and would register highest CAGR throughout the forecast period of 2015-2020. Based on stake holders, the market is segmented into mobile operators, device vendors, healthcare providers and application players. Mobile operators occupy the dominant share in the mHealth stakeholders market, whereas, the application players would register highest CAGR during the forecast period 2015-2020. Furthermore, based on applications, the mHealth market is segmented into cardiovascular diseases, diabetes, respiratory diseases, neurological diseases and others. Cardiovascular diseases is found to be the highest revenue generating segment, whereas diabetes is expected to register the highest CAGR during the forecast period 2015-2020. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America holds the dominant share in the global mHealth market. Asia-Pacific is found to be the fastest growing segment.

The players profiled in this report include - Philips Healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch AG, Cardionet Inc., Masimo Corporation, Sanofi S.A., Boston Scientific Corporation, AT&T Inc. and Johnson & Johnson. Product launch and collaboration are some of the key strategies adopted by the players in global mHealth market. For example, in January 2015, Masimo Corporation launched MightySat, a Fingertip Pulse Oximeter with Masimo SET Measure-through Motion and Low Perfusion Technology. Moreover, in March 2015, Omron launched smartphone connected activity tracker and fitness app.

KEY MARKET BENEFITS:

  • The report covers the detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
  • The mHealth market scenario is comprehensively analyzed based on the key regions
  • Key market players within the mHealth market are profiled in the report and their strategies are analyzed thoroughly, which helps in understanding the competitive outlook of the market
  • Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
  • Comprehensive analysis of factors that drive and restrict the growth of the global mHealth market, is provided in the report
  • Exhaustive analysis of the global mHealth market by device type helps in understanding the types of devices that are currently being used along with the variants that would gain prominence in future

KEY MARKET SEGMENTS:

  • Global mHealth Market- By Devices
    • Blood glucose meters
    • BP monitors
    • Pulse oximetry
    • Neurological monitoring devices
    • Apnea and sleep monitors
    • Wearable fitness sensor device & heart rate meters
    • Others
  • Global mHealth Market- By Services
    • Diagnosis services
    • Monitoring services
    • Prevention
    • Treatment and healthcare system strengthening solutions
  • Global mHealth Market- By Stakeholders
    • Mobile operators
    • Device vendors
    • Healthcare providers
    • Application players
  • Global mHealth Market- By Application
    • Cardiovascular diseases
    • Diabetes
    • Respiratory diseases
    • Neurological diseases
    • Others
  • Global mHealth Market- By Geography
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • Australia
      • Japan
      • China
      • India
      • Rest of Asia-pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa

Table of Contents

CHAPTER 1-INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits
  • 1.3. Key market segments
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2-EXECUTIVE SUMMARY

  • 2.1. CXO prospective
  • 2.2. Market beyond what expected by 2025($million)
    • 2.2.1. Base case scenario
    • 2.2.2. Rapid growth scenario
    • 2.2.3. Critical growth scenario

CHAPTER 3-MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top factors impacting global mHealth market
    • 3.2.2. Top investment pockets- global mHealth market
    • 3.2.3. Top winning strategies- global mHealth market
  • 3.3. Porters five forces analysis
    • 3.3.1. Bargaining power of buyers
    • 3.3.2. Bargaining power of suppliers
    • 3.3.3. Threat of new entrants
    • 3.3.4. Threat of substitute
    • 3.3.5. Intense competitive rivalry
  • 3.4. Value chain analysis
    • 3.4.1. Primary activities
    • 3.4.2. Secondary activities
  • 3.5. Regulatory issues, legislations and authorities
    • 3.5.1. Regulations and Directives pertaining to mHealth in the U.S.
    • 3.5.2. Regulations and directives pertaining to mHealth in EU
  • 3.6. Insurance and reimbursement scenario
  • 3.7. Market player positioning 2014
  • 3.8. Clinical trials (2011-2015)
  • 3.9. Patent analysis (2011-2015)
    • 3.9.1. US patent analysis
    • 3.9.2. Europe patent analysis
    • 3.9.3. Japan patent analysis
  • 3.10. Market dynamics
    • 3.10.1. Drivers
      • 3.10.1.1. Integration of wireless technologies with portable healthcare devices
      • 3.10.1.2. Increase in incidences of lifestyle disease
      • 3.10.1.3. Cost and Convenience Factors
      • 3.10.1.4. Technological innovations
      • 3.10.1.5. Government initiative
      • 3.10.1.6. Affordability of smartphones
    • 3.10.2. Restrains
      • 3.10.2.1. Lower adoption due to lack of awareness and technology infancy in developing and under developed region
      • 3.10.2.2. Weak reimbursement coverage
      • 3.10.2.3. Technological awareness among the ageing population
      • 3.10.2.4. Uncertainty in the government regulations is expected to hinder the growth rate
    • 3.10.3. Opportunities
      • 3.10.3.1. Untapped market of developing economies
      • 3.10.3.2. Rising Opportunities in the form of bundled services

CHAPTER 4-GLOBAL MHEALTH MARKET, BY DEVICES, 2014-2020

  • 4.1. Blood glucose meter
    • 4.1.1. Key market trends
    • 4.1.2. Growth factors and opportunity
    • 4.1.3. Market size and forecast
  • 4.2. BP monitors
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunity
    • 4.2.3. Market size and forecast
  • 4.3. Pulse oximetry
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and Opportunity
    • 4.3.3. Market size and forecast
  • 4.4. Neurological monitoring
    • 4.4.1. Key market trends
    • 4.4.2. Growth factors and Opportunity
    • 4.4.3. Market size and forecast
  • 4.5. Cardiac monitors
    • 4.5.1. Key market trends
    • 4.5.2. Growth factors and Opportunity
    • 4.5.3. Market size and forecast
  • 4.6. Apnea and sleep monitors
    • 4.6.1. Key market trends
    • 4.6.2. Growth factors and Opportunity
    • 4.6.3. Market size and forecast
  • 4.7. Wearable fitness sensor device and Heart Rate Meters
    • 4.7.1. Key market trends
    • 4.7.2. Growth factors and Opportunity
    • 4.7.3. Market size and forecast
  • 4.8. Others
    • 4.8.1. Key market trends
    • 4.8.2. Growth factors and opportunity
    • 4.8.3. Market size and forecast

CHAPTER 5-GLOBAL MHEALTH MARKET, BY SERVICES, 2014-2020

  • 5.1. Prevention
    • 5.1.1. Market size and forecast
  • 5.2. Diagnostic services
    • 5.2.1. Market size and forecast
    • 5.3. Monitoring services
    • 5.3.1. Market size and forecast
  • 5.4. Treatment
    • 5.4.1. Market size and forecast
  • 5.5. Wellness and healthcare system strengthening solutions
    • 5.5.1. Market size and forecast

CHAPTER 6-GLOBAL MHEALTH MARKET, BY STAKEHOLDERS, 2014-2020

  • 6.1. Mobile operators
    • 6.1.1. Market size and forecast
  • 6.2. Device vendors
    • 6.2.1. Market size and forecast
  • 6.3. Healthcare Providers
    • 6.3.1. Market size and forecast
  • 6.4. Application/ Content Players
    • 6.4.1. Market size and forecast

CHAPTER 7-GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2020

  • 7.1. Cardiovascular
    • 7.1.1. Market size and forecast
  • 7.2. Diabetes
    • 7.2.1. Market size and forecast
  • 7.3. Respiratory
    • 7.3.1. Market size and forecast
  • 7.4. Neurology
    • 7.4.1. Market size and forecast

CHAPTER 8-GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2020

  • 8.1. North America
    • 8.1.1. Key market trends
    • 8.1.2. Key growth factors and opportunity
    • 8.1.3. Market size and forecast
    • 8.1.4. United States
      • 8.1.4.1. Market size and forecast
    • 8.1.5. Canada
      • 8.1.5.1. Market size and forecast
    • 8.1.6. Mexico
      • 8.1.6.1. Market size and forecast
  • 8.2. Europe
    • 8.2.1. Key market trends
    • 8.2.2. Key growth factors and opportunity
    • 8.2.3. Market size and forecast
    • 8.2.4. France
      • 8.2.4.1. Market size and forecast
    • 8.2.5. Germany
      • 8.2.5.1. Market size and forecast
    • 8.2.6. United Kingdom
      • 8.2.6.1. Market size and forecast
    • 8.2.7. Italy
      • 8.2.7.1. Market size and forecast
    • 8.2.8. Russia
      • 8.2.8.1. Market size and forecast
    • 8.2.9. Rest of Europe
      • 8.2.9.1. Market size and forecast
  • 8.3. Asia-Pacific
    • 8.3.1. Key market trends
    • 8.3.2. Key growth factors and opportunity
    • 8.3.3. Market size and forecast
    • 8.3.4. Australia
      • 8.3.4.1. Market size and forecast
    • 8.3.5. China
      • 8.3.5.1. Market size and forecast
    • 8.3.6. Japan
      • 8.3.6.1. Market size and forecast
    • 8.3.7. India
      • 8.3.7.1. Market size and forecast
    • 8.3.8. Rest of Asia-pacific
      • 8.3.8.1. Market size and forecast
  • 8.4. LAMEA
    • 8.4.1. Key market trends
    • 8.4.2. Key growth factors and opportunity
    • 8.4.3. Market size and forecast
    • 8.4.4. Latin America
      • 8.4.4.1. Market size and forecast
    • 8.4.5. Middle East
      • 8.4.5.1. Market size and forecast
    • 8.4.6. Africa
      • 8.4.6.1. Market size and forecast

CHAPTER 9-COMPANY PROFILES

  • 9.1. LifeWatch AG
    • 9.1.1. Company overview
    • 9.1.2. LifeWatch AG snapshot
    • 9.1.3. Operating business segment overview
    • 9.1.4. Business performance
    • 9.1.5. Strategic moves and development
    • 9.1.6. SWOT analysis of LifeWatch AG
  • 9.2. Masimo Corporation
    • 9.2.1. Company overview
    • 9.2.2. Masimo Corporation snapshot
    • 9.2.3. Operating business segment overview
    • 9.2.4. Business performance
    • 9.2.5. Strategic moves and developments
    • 9.2.6. SWOT analysis of Masimo Corporation
  • 9.3. Omron healthcare
    • 9.3.1. Company overview
    • 9.3.2. Omron Healthcare snapshot
    • 9.3.3. Operating business segment overview
    • 9.3.4. Business performance
    • 9.3.5. Strategic moves and developments
    • 9.3.6. SWOT analysis of Omron Healthcare Inc.
  • 9.4. Philips healthcare (a division of Royal Philips company)
    • 9.4.1. Company overview
    • 9.4.2. Philips Healthcare snapshot
    • 9.4.3. Operating business segment overview
    • 9.4.4. Business performance
    • 9.4.5. Strategic moves and developments
    • 9.4.6. SWOT analysis of Philips Healthcare
  • 9.5. Bayer healthcare (a division of Bayer)
    • 9.5.1. Company overview
    • 9.5.2. Bayer Healthcare snapshot
    • 9.5.3. Operating Business Segment overview
    • 9.5.4. Business performance
    • 9.5.5. Strategic moves and development
    • 9.5.6. SWOT Analysis Of Bayer Healthcare
  • 9.6. Sanofi
    • 9.6.1. Company overview
    • 9.6.2. Sanofi snapshot
    • 9.6.3. Operating business segment overview
    • 9.6.4. Business performance
    • 9.6.5. Strategic moves and developments
    • 9.6.6. SWOT analysis of Sanofi
  • 9.7. Boston Scientific Corporation
    • 9.7.1. Company overview
    • 9.7.2. Boston Scientific Corporation snapshot
    • 9.7.3. Operating business segment
    • 9.7.4. Business performance
    • 9.7.5. Strategic moves and developments
    • 9.7.6. SWOT analysis of Boston Scientific Corporation
  • 9.8. AT&T Inc.
    • 9.8.1. Company overview
    • 9.8.2. AT&T Inc. snapshot
    • 9.8.3. Operating business segment
    • 9.8.4. Business performance
    • 9.8.5. Strategic moves and developments
    • 9.8.6. SWOT analysis of AT&T Inc.
  • 9.9. JOHNSON & JOHNSON
    • 9.9.1. Company overview
    • 9.9.2. Johnson & Johnson Inc. snapshot
    • 9.9.3. Operating business segment overview
    • 9.9.4. Business performance
    • 9.9.5. Strategic moves and developments
    • 9.9.6. SWOT analysis of Johnson & Johnson Inc.

List of Tables

  • TABLE 1: GLOBAL MHEALTH MARKET BY GEOGRAPHY, MODERATE GROWTH SCENARIO, 2020 - 2025, ($MILLION)
  • TABLE 2: GLOBAL MHEALTH MARKET BY GEOGRAPHY, RAPID GROWTH SCENARIO, 2020 - 2025, ($MILLION)
  • TABLE 3: GLOBAL MHEALTH MARKET BY GEOGRAPHY, CRITICAL GROWTH SCENARIO, 2020 - 2025, ($MILLION)
  • TABLE 4: CLINICAL TRIALS 2011-2015
  • TABLE 5: PATENT ANALYSIS- UNITED STATES (2011-2014)
  • TABLE 6: PATENT ANALYSIS- EUROPE (2011-2014)
  • TABLE 7: PATENT ANALYSIS- JAPAN (2011-2014)
  • TABLE 8: GLOBAL MHEALTH MARKET, BY DEVICES, 2014-2020 ($MILLION)
  • TABLE 9: DIABETES RELATED SMART PHONE APPLICATIONS
  • TABLE 10: GLOBAL MHEALTH BLOOD GLUCOSE METERS MARKET, BY GEOGRAPHY, 2014 - 2020($MILLION)
  • TABLE 11: MOBILE COMPATIBLE BP MONITORS
  • TABLE 12: GLOBAL MHEALTH BP MONITORS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 13: AVAILABLE PULSE OXIMETERS AND ITS COST
  • TABLE 14: GLOBAL MHEALTH PULSE OXIMETERY MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 15: GLOBAL MHEALTH NEUROLOGICAL MONITORS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 16: GLOBAL MHEALTH CARDIAC MONITORS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 17: SLEEP AND APNEA DEVICES
  • TABLE 18: GLOBAL MHEALTH APNEA & SLEEP MONITORS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 19: WEARABLE FITNESS DEVICES AND ITS COST
  • TABLE 20: GLOBAL MHEALTH WEARABLE FITNESS SENSOR DEVICES AND HEART RATE METERS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 21: GLOBAL MHEALTH OTHER DEVICES MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 22: GLOBAL M-HEALTH SERVICES MARKET, BY TYPE, 2014-2020 ($MILLION)
  • TABLE 23: GLOBAL M-HEALTH SERVICES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 24: SMARTPHONE APPS FOR PREVENTIVE SERVICES
  • TABLE 25: MOBILE HEALTHCARE SOLUTION PROVIDED BY CDAC
  • TABLE 26: GLOBAL MHEALTH PREVENTION SERVICE MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 27: GLOBAL MHEALTH DIAGNOSIS SERVICE MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 28: GLOBAL MHEALTH MONITORING SERVICE MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 29: GLOBAL MHEALTH TREATMENT SERVICE MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 30: GLOBAL MHEALTH WELLNESS AND HEALTHCARE SYSTEMS STRENGTHENING SOLUTIONS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 31: GLOBAL MHEALTH MARKET, BY STAKEHOLDERS,2014 - 2020 ($MILLION)
  • TABLE 32: GLOBAL MHEALTH STAKEHOLDERS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 33: GLOBAL MHEALTH MOBILE OPERATORS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 34: GLOBAL MHEALTH DEVICE VENDORS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 35: GLOBAL MHEALTH HEALTHCARE PROVIDERS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 36: GLOBAL MHEALTH APPLICATION/CONTENT PLAYERS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 37: GLOBAL MHEALTH MARKET BY APPLICATION, 2014 - 2020 ($MILLION)
  • TABLE 38: GLOBAL MHEALTH APPLICATION MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 39: GLOBAL MHEALTH CARDIOVASCULAR APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 40: PREVALENCE AND PROJECTIONS (DIABETES)
  • TABLE 41: GLOBAL MHEALTH DIABETES APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 42: GLOBAL MHEALTH RESPIRATORY APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 43: GLOBAL NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS PROJECTION FOR 2015 AND 2030
  • TABLE 44: GLOBAL MHEALTH NEUROLOGY APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 45: IMPACT ANALYSIS PENETRATING TO GEOGRAPHY 2014
  • TABLE 46: NORTH AMERICA MHEALTH DEVICES MARKET BY COUNTRY, 2014 - 2020 ($MILLION)
  • TABLE 47: UNITED STATES MHEALTH MARKET (DEVICES AND SERVICES), 2014-2020, ($MILLION)
  • TABLE 48: CANADA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 49: EUROPE MHEALTH DEVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
  • TABLE 50: EUROPE MHEALTH SERVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
  • TABLE 51: FRANCE MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 52: GERMANY MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 53: UNITED KINGDOM (DEVICES AND SERVICES) MHEALTH MARKET, 2014-2020, ($MILLION)
  • TABLE 54: ITALY MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 55: RUSSIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
  • TABLE 56: REST OF EUROPE MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 57: ASIA-PACIFIC MHEALTH DEVICES MARKET, BY COUNTRY, 2014-2020, ($MILLION)
  • TABLE 58: ASIA-PACIFIC MHEALTH SERVICES MARKET, BY COUNTRY, 2014-2020, ($MILLION)
  • TABLE 59: AUSTRALIA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 60: CHINA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 61: JAPAN MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
  • TABLE 62: INDIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
  • TABLE 63: REST OF ASIA-PACIFIC MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 64: LAMEA MHEALTH DEVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
  • TABLE 65: LAMEA MHEALTH SERVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
  • TABLE 66: LATIN AMERICA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 67: MIDDLE EAST MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 68: AFRICA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 69: LIFEWATCH AG COMPANY SNAPSHOT
  • TABLE 70: MASIMO CORPORATION SNAPSHOT
  • TABLE 71: OPERATING SEGMENT
  • TABLE 72: OMRON HEALTHCARE SNAPSHOT
  • TABLE 73: OPERATING BUSINESS SEGMENT OVERVIEW
  • TABLE 74: PHILIPS HEALTHCARE SNAPSHOT
  • TABLE 75: OPERATING BUSINESS SEGMENT OVERVIEW
  • TABLE 76: BAYER HEALTHCARE SNAPSHOT
  • TABLE 77: OPERATING BUSINESS SEGMENT OVERVIEW
  • TABLE 78: SANOFI SNAPSHOT OF SANOFI
  • TABLE 79: OPERATING BUSINESS SEGMENTS OVERVIEW
  • TABLE 80: BOSTON SCIENTIFIC CORPORATION SNAPSHOT
  • TABLE 81: OPERATING BUSINESS SEGMENT
  • TABLE 82: AT&T INC. SNAPSHOT
  • TABLE 83: OPERATING BUSIMESS SEGMENT
  • TABLE 84: JOHNSON & JOHNSON INC. COMPANY SNAPSHOT
  • TABLE 85: OPERATING BUSINESS

List of Figures

  • FIG. 1: IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN MODERATE GROWTH SCENARIO
  • FIG. 2: IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN RAPID GROWTH SCENARIO
  • FIG. 3: IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN CRITICAL GROWTH SCENARIO
  • FIG. 4: TOP IMPACTING FACTORS OF GLOBAL MHEALTH MARKET 2014-2020
  • FIG. 5: TOP INVESTMENT POCKETS
  • FIG. 6: TOP WINNING STRATEGIES
  • FIG. 7: PORTER'S FIVE FORCES ANALYSIS
  • FIG. 8: VALUE CHAIN ANALYSIS OF GLOBAL MHEALTH MARKET
  • FIG. 9: MARKET PLAYER POSITIONING 2014
  • FIG. 10: PATENT ANALYSIS, BY GEOGRAPHY, 2011-2015
  • FIG. 11: US PATENT ANALYSIS
  • FIG. 12: EUROPE PATENT ANALYSIS
  • FIG. 13: JAPAN PATENT ANALYSIS
  • FIG. 14: GLOBAL PER CAPITA SMARTPHONE PENETRATION (2011-2018)
  • FIG. 15: ESTIMATED DEATH DUE TO CVDS (MILLION)
  • FIG. 16: PENETRATION OF SMARTPHONE USERS BY APPLICATIONS
  • FIG. 17: MHEALTH INITIATIVE BY WORLD HEALTH ORGANIZATION
  • FIG. 18: SMARTPHONE OWNERSHIP IN UNITED STATES (2011-2014)
  • FIG. 19: HEART RATE MONITORS
  • FIG. 20: DEATHS DUE TO CVD
  • FIG. 21: ASTHMA PREVALENCE IN UNITED STATES IN 2011
  • FIG. 22: CANADIAN'S OPINION ABOUT HEALTHCARE SYSTEM
  • FIG. 23: BUSINESS PERFORMANCE OF LIFEWATCH 2012-2014 ($MILLION)
  • FIG. 24: REVENUE BY BUSINESS SEGMENT (2014)
  • FIG. 25: REVENUE BY REGION (2014)
  • FIG. 26: SWOT ANALYSIS OF LIFEWATCH AG
  • FIG. 27: BUSINESS PERFORMANCE OF MASIMO 2012-2014 ($MILLION)
  • FIG. 28: SWOT ANALYSIS OF MASIMO CORPORATION
  • FIG. 29: NET SALES OF OMRON ($MILLION)
  • FIG. 30: OMRON'S NET SALES BY OPERATING SEGMENT (2013)
  • FIG. 31: OMRON'S NET SALES BY REGION (2013)
  • FIG. 32: SWOT ANALYSIS OF OMRON HEALTHCARE INC.
  • FIG. 33: PHILIPS NET SALES 2012-2014 ($MILLION)
  • FIG. 34: PHILIPS HEALTHCARE REVENUE BY OPERATING SEGMENT (2014)
  • FIG. 35: SWOT ANALYSIS OF PHILIPS HEALTHCARE
  • FIG. 36: NET SALES OF BAYER HEALTHCARE 2012-2014 ($MILLION)
  • FIG. 37: BAYER HEALTHCARE'S REVENUE BY OPERATING SEGMENT IN 2014
  • FIG. 38: SWOT ANALYSIS OF BAYER HEALTHCARE
  • FIG. 39: NET SALES OF SANOFI 2012-2014 ($MILLION)
  • FIG. 40: NET SALES OF SANOFI BY OPERATING SEGMENT (2014)
  • FIG. 41: NET SALES OF SANOFI BY GEOGRAPHY 2014
  • FIG. 42: SWOT ANALYSIS OF SANOFI
  • FIG. 43: OPERATIONAL SALES OF BOSTON SCIENTIFIC 2012-2014 ($MILLION)
  • FIG. 44: OPERATIONAL SALES BY OPERATING SEGMENT 2014
  • FIG. 45: SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION
  • FIG. 46: REVENUE OF AT&T INC. 2012-2014 ($MILLION)
  • FIG. 47: SWOT ANALYSIS OF AT&T INC.
  • FIG. 48: NET SALES OF JOHNSON & JOHNSON 2012-2014 ($MILLION)
  • FIG. 49: NET SALES BY OPERATING SEGMENT 2014
  • FIG. 50: SWOT ANALYSIS OF JOHNSON & JOHNSON INC.
Back to Top